January 11-15, 2027 | San Francisco
2027 Participating Companies
Enanta discovered glecaprevir in the leading HCV cure Mavyret and is using its chemistry-driven expertise to deliver novel therapeutics for virology, dermatology and respiratory diseases. (PLEASE NO CRO/CMO REQUESTS.)